UK markets closed

Roquefort Therapeutics plc (ROQ.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
5.250.00 (0.00%)
At close: 04:16PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
Total revenue
200
200
0
Cost of revenue
-
-
0
Gross profit
-
-
0
Operating expenses
Research development
620.159
620.159
319.315
Selling general and administrative
642.86
642.86
940.997
Total operating expenses
2,134
2,134
1,634
Operating income or loss
-1,934
-1,934
-1,634
Interest expense
0.058
0.058
0
Income before tax
-1,932
-1,932
-1,634
Income tax expense
-187.693
-187.693
-18.886
Income from continuing operations
-1,745
-1,745
-1,615
Net income
-1,745
-1,745
-1,615
Net income available to common shareholders
-1,745
-1,745
-1,615
Basic EPS
-0.00
-0.01
-0.02
Diluted EPS
-0.00
-0.01
-0.02
Basic average shares
145,800
129,150
103,479
Diluted average shares
145,800
129,150
103,479